A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Beth Israel Med. Ctr. (Mt. Sinai), New York

NY Univ. HIV/AIDS CRS, New York

Univ. of Rochester ACTG CRS, Rochester

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

Johns Hopkins Adult AIDS CRS, Baltimore

Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro

Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte

Alabama Therapeutics CRS, Birmingham

Case CRS, Cleveland

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Univ. of Iowa Healthcare, Div. of Infectious Diseases, Iowa City

University of Minnesota, ACTU, Minneapolis

Northwestern University CRS, Chicago

Weiss Memorial Hosp., Chicago

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Tulane Hemophilia Treatment Ctr., New Orleans

University of Colorado Hospital CRS, Aurora

Harbor-UCLA Med. Ctr. CRS, Torrance

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

University of Washington AIDS CRS, Seattle

Unc Aids Crs, Chapel Hill

Univ. of Miami AIDS CRS, Miami

The Ohio State Univ. AIDS CRS, Columbus

MetroHealth CRS, Cleveland

Univ. of Cincinnati CRS, Cincinnati

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha

Ucsd, Avrc Crs, San Diego

Stanford CRS, Palo Alto

San Mateo County AIDS Program, San Mateo

Massachusetts General Hospital ACTG CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Washington U CRS, St Louis

Beth Israel Med. Ctr., ACTU, New York